Markets:

Overview

News

Currencies

International

Treasuries

Cabaletta Bio, Inc. - Common Stock (NQ:CABA)

2.990 +0.650 (+27.78%)

Streaming Delayed Price Updated: 12:40 PM EST, Jan 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cabaletta Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

50 Biggest Movers From Yesterday ↗

December 15, 2021

Gainers Sidus Space, Inc. (NASDAQ: SIDU) shares jumped 143.8% to settle at $12.19 on Tuesday after the company priced its IPO at $5 per share, MIND Technology, Inc. (NASDAQ: MIND...

Via Benzinga

Mid-Afternoon Market Update: Dow Falls 100 Points; Terminix Shares Spike Higher ↗

December 14, 2021

Toward the end of trading Tuesday, the Dow traded down 0.30% to 35,544.59 while the NASDAQ fell 1.53% to 15,176.99. The S&P also fell, dropping 0.93% to 4,625.65. The U.S. has...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 14, 2021

Gainers Galera Therapeutics (NASDAQ:GRTX

Via Benzinga

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Cabaletta Bio's Cell Therapy Fails To Show Activity At Low Doses In Skin Blistering Disorder ↗

December 14, 2021

Cabaletta Bio Inc's (NASDAQ: CABA) DSG3-CAART fails to show biologic activity to date in the two lowest cell dose cohorts of Phase 1 trial mucosal Pemphigus...

Via Benzinga

Mid-Day Market Update: Nasdaq Tumbles 200 Points; MIND Technology Shares Jump ↗

December 14, 2021

Midway through trading Tuesday, the Dow traded down 0.17% to 35,588.72 while the NASDAQ fell 1.3% to 15,213. The S&P also fell, dropping 0.80% to 4,631.69. The U.S. has the...

Via Benzinga

34 Stocks Moving In Tuesday's Mid-Day Session ↗

December 14, 2021

Gainers Exicure, Inc. (NASDAQ: XCUR) rose 41.8% to $0.3830. Exicure’s Audit Committee recently concluded that Grant Corbett misreported raw data from certain R&D...

Via Benzinga

Mid-Morning Market Update: Markets Mostly Lower; Producer Prices Rise 0.8% In November ↗

December 14, 2021

Following the market opening Tuesday, the Dow traded up 0.06% to 35,673.60 while the NASDAQ fell 1.08% to 15,247.22. The S&P also fell, dropping 0.57% to 4,642.29. The U.S....

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021 ↗

December 08, 2021

Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD...

Via Benzinga

Cabaletta Posts Cell Therapy Data From Third Cohort Of Autoimmune Skin Disorder Trial ↗

November 01, 2021

Cabaletta Bio Inc (NASDAQ: CABA) has announced 28-day clinical data from the third dose cohort (500 million DSG3-CAART cells) in the DesCAARTes Phase 1 trial for...

Via Benzinga

30 Stocks Moving In Wednesday's Mid-Day Session ↗

September 08, 2021

Gainers Kadmon Holdings, Inc. (NASDAQ: KDMN) shares jumped 72.6% to $9.15. Sanofi announced Wednesday it has agreed to acquire New York-based biopharma Kadmon in a $1.9 billion...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 07, 2021

Gainers Cellectar Biosciences (NASDAQ:CLRB

Via Benzinga

Cabaletta Bio's Cell Therapy Shows Encouraging Safety Profile In Autoimmune Skin Disorder ↗

August 18, 2021

Cabaletta Bio Inc (NASDAQ: CABA) has announced 28-day data from the second dose cohort from the DesCAARTes Phase 1 trial of DSG3-CAART for mucosal-dominant...

Via Benzinga

63 Biggest Movers From Yesterday ↗

August 27, 2021

Gainers Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume. TSR, Inc. (NASDAQ: TSRI) shares rose 28.1% to close at $11...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 22, 2021

Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 53.01% to $15.47 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

August 04, 2021

Wednesday's morning session saw 58 companies set new 52-week lows. Noteworthy Mentions: The company with the largest market cap to set a new 52-week low was...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2021 ↗

June 30, 2021

Upgrades For Taiwan Semiconductor Manufacturing Co Ltd (NYSE:

Via Benzinga

The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal ↗

June 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 07, 2021

Gainers Atossa Therapeutics (NASDAQ:ATOS)...

Via Benzinga

60 Biggest Movers From Yesterday ↗

June 08, 2021

Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares surged 87.3% to close at $9.14 on Monday on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) gained 60.3% to settle...

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

June 07, 2021

Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares jumped 64.8% to $8.04 on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) surged 60.3% to $5.93 after the company...

Via Benzinga

Cabaletta Bio's Cell Therapy In Skin Blistering Disorder Shows Favorable Safety Profile ↗

May 03, 2021

Cabaletta Bio Inc (NASDAQ: CABA) has announced acute safety data from the first dose cohort of the ongoing DesCAARTes Phase 1 trial of DSG3-CAART...

Via Benzinga

50 Biggest Movers From Friday ↗

April 26, 2021

Gainers Sypris Solutions, Inc. (NASDAQ: SYPR) shares surged 59.1% to close at $4.47 on Friday after the company said its electronics unit has won a contract for deep space...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.